Drug shortage
Chewable · Sun Pharmaceutical Industries, Inc.
FDA drug shortage · Current · updated Apr 4, 2025
Key facts
| Generic name | Chewable, Lisdexamfetamine Dimesylate Tablet |
|---|---|
| Proprietary name | Lisdexamfetamine Dimesylate |
| Company | Sun Pharmaceutical Industries, Inc. |
| Presentation | Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) |
| Dosage form | Chewable, Tablet |
| Strength | 50 mg |
| Status | Current |
| Reason for shortage | Shortage of an active ingredient |
| Therapeutic category | Psychiatry |
| Package NDCs | 57664-087-88 |
| First posted | Jul 14, 2023 |
| Last updated | Apr 4, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: